PTLA

Portola Pharmaceuticals, Inc.
PTLA

Overview Fund Activity
Delisted

PTLA was delisted on the 1st of July, 2020.

Back to rankings

190 hedge funds and large institutions have $2.66B invested in Portola Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 86 increasing their positions, 44 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
190
Holders Change
+19
Holders Change %
+11.11%
% of All Funds
4.99%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.16%
New
36
Increased
86
Reduced
44
Closed
16
Calls
$9.91M
Puts
$15.2M
Net Calls
-$5.24M
Net Calls Change
+$1.99M

Top Buyers

1
Temasek Holdings
Temasek Holdings
Singapore
+$38.6M
2
Millennium Management
Millennium Management
New York
+$30.3M
3
Marshall Wace
Marshall Wace
United Kingdom
+$29.6M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$29.1M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$25.7M

Top Sellers

1
MAM
MPM Asset Management
Massachusetts
-$52M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$48.2M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$46.4M
4
Franklin Resources
Franklin Resources
California
-$18.6M
5
BCM
BBT Capital Management
Texas
-$8.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
Geode Capital Management
26
Geode Capital Management
Massachusetts
$20.8M +$2.28M +44,231 +12%
AllianceBernstein
27
AllianceBernstein
Tennessee
$17.6M -$772 -15 -0%
Deutsche Bank
28
Deutsche Bank
Germany
$16.4M -$1.98M -38,406 -11%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$15.2M +$1.53M +29,675 +11%
Wells Fargo
30
Wells Fargo
California
$15.1M +$542K +10,544 +4%
HCMT
31
Highland Capital Management (Texas)
Texas
$15.1M -$2.27M -44,110 -13%
Loomis, Sayles & Company
32
Loomis, Sayles & Company
Massachusetts
$14.8M +$14.8M +287,370 New
VOYA Investment Management
33
VOYA Investment Management
Georgia
$14.5M +$68.2K +1,325 +0.5%
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$14.4M -$5.93M -115,350 -29%
Morgan Stanley
35
Morgan Stanley
New York
$12.1M +$816K +15,853 +7%
Axa
36
Axa
France
$11.8M -$249K -4,836 -2%
GTC
37
Ghost Tree Capital
New York
$11.8M +$10.5M +205,000 +820%
Artisan Partners
38
Artisan Partners
Wisconsin
$11.5M +$1.12M +21,860 +11%
FAM
39
Fred Alger Management
New York
$11.3M -$1.1M -21,311 -9%
EA
40
Emerald Advisers
Pennsylvania
$11.1M +$1.29M +25,156 +13%
Lord, Abbett & Co
41
Lord, Abbett & Co
New Jersey
$11M +$11M +213,903 New
FIM
42
Fernwood Investment Management
Massachusetts
$10.6M +$823K +16,000 +8%
EMFAT
43
Emerald Mutual Fund Advisers Trust
Pennsylvania
$10.4M +$552K +10,730 +6%
Bank of America
44
Bank of America
North Carolina
$10.4M +$740K +14,385 +8%
Invesco
45
Invesco
Georgia
$10.3M +$267K +5,189 +3%
UBS AM
46
UBS AM
Illinois
$10.3M -$337K -6,540 -3%
TCIM
47
TIAA CREF Investment Management
New York
$9.98M +$301K +5,859 +3%
GH
48
GAM Holding
Switzerland
$9.45M -$1.5M -29,124 -14%
PI
49
Putnam Investments
Massachusetts
$9.43M -$2.11M -40,965 -18%
Charles Schwab
50
Charles Schwab
California
$9.32M +$948K +18,428 +11%
1
2
3 4 5